Next Generation Sequencing for Potential Regulated Genes and Micro-RNAs of Early Growth Response-1 in the Esophageal Squamous Cell Carcinoma

Overview

Journal Protein J

Publisher Springer

Specialty Biochemistry

Date 2022 Oct 7

PMID 36207572

Authors

Yen-Chiang Tseng

Chih-Wen Shu

Hui-Min Chang

Yi-Hsuan Lin

Yen-Han Tseng

Han-Shui Hsu

Yih-Gang Goan

Ching-Jiunn Tseng

Affiliations

Soon will be listed here.

Abstract

Esophageal cancer has a poor prognosis due to its aggressiveness and low survival rate. In Ease Asia, esophageal squamous cell carcinoma (ESCC) outnumbers esophageal adenocarcinoma (EAC). The ESCC patients still have high mortality despite modern surgical resection and neoadjuvant treatment. Determining patient and outcome prognostic factors is critical in ESCC treatment. In esophageal cancer, early growth response-1 (Egr-1) is a tumor suppressor gene, but the mechanism and associated genes are unknown. The study utilizes RNA interference method, the platform of Next Generation Sequencing (NGS) and bioinformatics analysis to investigate the influences after the Egr-1 gene slicing on the ESCC cells. The heat maps of differentially expressed mRNA and microRNAs were analyzed using the algorithm, Burrows-Wheller Aligner. The study showed that the expression of 51 mRNA and 26 microRNAs have significant changes in ESCC cells after Egr-1 knockdown. The KEGG enrichment analysis linked Egr-1-regulated genes and microRNAs. Egr-1 interactions with these genes and microRNAs may be important in tumor progression. In conclusions, this study provided the transcriptome patterns and relating pathway analysis for Egr-1 knockdown in ESCC cells. The mRNA and microRNAs altered by Egr-1 gene silencing might provide key information in the treatment of ESCC.

References

Verma S, Das P . Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma. PLoS One. 2018; 13(10):e0205660. PMC: 6193652. DOI: 10.1371/journal.pone.0205660. View

Zhao Y, Xia Q, Liu Y, Bai W, Yao Y, Ding J . TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells. Cell Signal. 2018; 55:8-16. DOI: 10.1016/j.cellsig.2018.12.007. View

Wang J, Yu P, Luo J, Sun Z, Yu J, Wang J . Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC). Front Pharmacol. 2021; 12:626972. PMC: 8082678. DOI: 10.3389/fphar.2021.626972. View

Wang B, Wu S, Chen H, Hung W, Lin C, Huang C . Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Br J Surg. 2018; 106(3):255-262. DOI: 10.1002/bjs.11004. View

Li S, Guo R, Peng Z, Quan B, Hu Y, Wang Y . NPR3, transcriptionally regulated by POU2F1, inhibits osteosarcoma cell growth through blocking the PI3K/AKT pathway. Cell Signal. 2021; 86:110074. DOI: 10.1016/j.cellsig.2021.110074. View

Hsu P, Li A, Wang Y, Hsieh C, Huang M, Hsu W . Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg. 2008; 135(5):1029-35. DOI: 10.1016/j.jtcvs.2007.11.007. View

Gu L, Lu L, Zhou D, Liu Z . Long Noncoding RNA BCYRN1 Promotes the Proliferation of Colorectal Cancer Cells via Up-Regulating NPR3 Expression. Cell Physiol Biochem. 2018; 48(6):2337-2349. DOI: 10.1159/000492649. View

Ziegler A, Corvalan A, Roa I, Branes J, Wollscheid B . Teneurin protein family: an emerging role in human tumorigenesis and drug resistance. Cancer Lett. 2012; 326(1):1-7. DOI: 10.1016/j.canlet.2012.07.021. View

Wang T, Gu J, Li Y . Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method. BMC Bioinformatics. 2014; 15:255. PMC: 4124158. DOI: 10.1186/1471-2105-15-255. View

10.

Yun S, Vincelette N, Knorr K, Almada L, Schneider P, Peterson K . 4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells. Blood. 2016; 127(22):2711-22. PMC: 4891953. DOI: 10.1182/blood-2015-02-629485. View

11.

Meredith K, Weber J, Turaga K, Siegel E, McLoughlin J, Hoffe S . Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer. Ann Surg Oncol. 2010; 17(4):1159-67. DOI: 10.1245/s10434-009-0862-1. View

12.

Qin G, Yang L, Ma Y, Liu J, Huo Q . The exploration of disease-specific gene regulatory networks in esophageal carcinoma and stomach adenocarcinoma. BMC Bioinformatics. 2020; 20(Suppl 22):717. PMC: 6936086. DOI: 10.1186/s12859-019-3230-6. View

13.

Sakai N, Samia-Aly E, Barbera M, Fitzgerald R . A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013; 23(6 Pt B):512-21. DOI: 10.1016/j.semcancer.2013.08.005. View

14.

Rustgi A, El-Serag H . Esophageal carcinoma. N Engl J Med. 2014; 371(26):2499-509. DOI: 10.1056/NEJMra1314530. View

15.

Gao X, Xie Z, Wang Z, Cheng K, Liang K, Song Z . Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Yonsei Med J. 2017; 58(6):1101-1110. PMC: 5653474. DOI: 10.3349/ymj.2017.58.6.1101. View

16.

Baron V, Adamson E, Calogero A, Ragona G, Mercola D . The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 2005; 13(2):115-24. PMC: 2455793. DOI: 10.1038/sj.cgt.7700896. View

17.

Qin L, Guo S, Han Y, Wang X, Zhang B . Functional mosaic organization of neuroligins in neuronal circuits. Cell Mol Life Sci. 2020; 77(16):3117-3127. PMC: 11104838. DOI: 10.1007/s00018-020-03478-y. View

18.

Zhang X, Li F, Zhou Y, Mao F, Lin Y, Shen S . Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer. Cell Death Dis. 2021; 12(7):627. PMC: 8213778. DOI: 10.1038/s41419-021-03917-z. View

19.

Abnet C, Arnold M, Wei W . Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2017; 154(2):360-373. PMC: 5836473. DOI: 10.1053/j.gastro.2017.08.023. View

20.

Zhao Z, Partridge V, Sousares M, Shelton S, Holland C, Pertsemlidis A . microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi. PLoS One. 2018; 13(12):e0208777. PMC: 6294380. DOI: 10.1371/journal.pone.0208777. View